Clal Biotechnology reported ILS35.76M in Debt for its fiscal quarter ending in December of 2023.


Debt Change Date
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.97M 58K Jun/2025
Life Technologies USD 1.84M 416K Jun/2025
RedHill Biopharma USD 356K 202K Dec/2024